Breaking News

Exclusive: Senators demand answers on telehealth from Pfizer and Eli Lilly

October 22, 2024
Jacquelyn Martin/AP

STAT+ | Michelle Tarver to lead FDA medical device center

Tarver joined the FDA's devices center in 2009, and has temporarily served in the role since the departure of devices head Jeffrey Shuren.

By Lizzy Lawrence


STAT+ | Editas tacks again, steering from lead sickle cell treatment to new one

One of the oldest CRISPR-focused biotechs will pivot to a sickle cell treatment that requires editing a patient's genes in the body.

By Jason Mast


In a bid to treat their children's rare diseases, these three parents founded companies

The founders of Angelman Syndrome Therapeutics, Elpida Therapeutics, Alltrna on starting companies to treat their children's rare diseases.

By Anil Oza



Sen. Dick Durbin (D-Ill.), who has advocated for price transparency in direct-to-consumer drug advertising, is now looking at drugmakers and telehealth prescribing.
Tom Brenner/Pool via AP

STAT+ | Senators demand answers on telehealth platforms from Pfizer and Eli Lilly

Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around old kickback laws.

By Katie Palmer


How a tragic diagnosis sent a journalist on a scientific odyssey

Ingrassia explains what he learned about a genetic mutation that runs in his family and that has led to a number of relatives dying at a young age.

By STAT Staff


Opinion: Primary care physicians should receive abortion training

Only 3% of recently graduated family physicians currently provide abortion care, largely due to lack of training.

By Christine Dehlendorf and Jody Steinauer


Lewis Joly/AP

Dietary experts advise skipping guidelines on ultra-processed foods — for now

Experts advising on dietary guidelines say it's premature to tackle ultra-processed foods. "In the next five years, research is going to explode."

By Elizabeth Cooney


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments